Top Analyst Reports For Novartis, McDonald's & Bristol-Myers Squibb

 | Jan 09, 2020 12:21AM ET

Thursday, January 9, 2020

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Novartis (NVS), McDonald's (MCD) and Bristol-Myers Squibb (BMY). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see

Today's Must Read/h6

Featured Reports/h6

Per the Zacks analyst, expansion of futures products in emerging markets and OTC offerings poise the company well for growth. However, higher expenses weigh on margins.

Per the Zacks analyst, buyouts have helped Chubb in domestic as well as international expansion and boosted the portfolio of products and services.

Per the Zacks analyst, UBS Group's cost saving measures to drive operational efficiency are encouraging.

Per the Zacks analyst, Activision's foray into e-sports and user base expansion from strength in popular franchises bodes well for its growth prospects.

Per the Zacks analyst, Workday's revenue growth continues to be driven by high demand for its HCM and financial management solutions.

Per the Zacks analyst, well performing Square Register, Build with Square and API platforms continue to aid growth in Square's gross payment volume.

Per the Zacks analyst, Abercrombie is well on track with its transformation initiatives like launch of expanded payment options and rebranding of loyalty program.

New Upgrades/h6

Better price/mix and higher volumes have been aiding sales at Lamb Weston's Global segment for a while now. Per the Zacks analyst, strength in this unit remains a tailwind for top line in fiscal 2020.

Per the Zacks analyst, MDU Resources' consistent and disciplined approach to the acquisition of well-managed companies and properties is expected to drive performance.

Per the Zacks analyst, Emergent's vaccine portfolio holds potential as newly-acquired products are making good progress.

New Downgrades/h6

Conservative capital spending program by drillers in the United States will continue to hurt Schlumberger's domestic oilfield service demand, per the Zacks analyst.

Per the Zacks analyst, uncertainties revolving around Boeing (NYSE:BA)'s 737 Max aircraft may hamper the stock's growth. Further, prolonged delays in Asco acquisition may further escalate its costs.

Per the Zacks Analyst, rising operational inefficiencies and high raw materials costs along with increasing labor expenses are clipping the firm's margins and the trend is likely to continue.


Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

undefined Zacks Investment Research

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes